Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SLGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 48.10M
March 31, 2026 51.41M
December 31, 2025 22.81M
September 30, 2025 26.03M
June 30, 2025 31.88M
March 31, 2025 20.17M
December 31, 2024 28.85M
September 30, 2024 34.70M
June 30, 2024 34.90M
March 31, 2024 32.65M
December 31, 2023 38.64M
September 30, 2023 43.13M
June 30, 2023 48.30M
March 31, 2023 44.06M
December 31, 2022 42.21M
September 30, 2022 47.47M
June 30, 2022 50.35M
March 31, 2022 50.12M
Date Value
December 31, 2021 55.59M
September 30, 2021 41.44M
June 30, 2021 39.25M
March 31, 2021 47.06M
December 31, 2020 50.85M
September 30, 2020 57.16M
June 30, 2020 65.52M
March 31, 2020 67.13M
December 31, 2019 52.46M
September 30, 2019 58.57M
June 30, 2019 54.74M
March 31, 2019 58.97M
December 31, 2018
September 30, 2018 74.91M
June 30, 2018 81.55M
March 31, 2018 87.04M
December 31, 2017 -52.70M
September 30, 2017 -48.98M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Teva Pharmaceutical Industries Ltd. 7.753B
RedHill Biopharma Ltd. --
MediWound Ltd. 35.64M
Purple Biotech Ltd. 12.27M
PolyPid Ltd. 5.388M

Shareholders Equity (Quarterly) Related Metrics